| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Operating Officer
1 company
Deschatelets Pascal is a Chief Scientific Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $48.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 2,277 | $22.19 | $50,520.25 | -0.2% | +91.2% | - | |
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 826 | $29.52 | $24,386.49 | - | -38.2% | -21.8% | |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,948 | $30.43 | $120,119.87 | -0.3% | -42.8% | -27.6% | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 750 | $29.96 | $22,468.65 | - | -39.2% | -33.4% | |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 2,288 | $28.70 | $65,670.40 | -0.2% | -32.4% | -25.4% | |
| May 8, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 78,907 | $42.35 | $3,341,848.01 | -2.3% | -17.0% | -57.9% | |
| Apr 8, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 69,107 | $54.17 | $3,743,605.22 | -3.0% | -31.2% | -65.2% | |
| Mar 8, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 69,107 | $62.19 | $4,297,549.18 | -2.0% | -33.4% | -59.4% | |
| Feb 12, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,148 | $67.77 | $77,796.40 | -0.1% | -36.5% | -57.9% | |
| Jan 29, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 874 | $64.14 | $56,056.79 | - | -26.8% | -55.2% |